Risk vs Prevalence: Weighing Routine DPYD Variant Testing Prior to Fluoropyrimidine-Based Chemotherapy
Get every episode summarized
Each time Clinical Chemistry Podcast publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
About this episode
No show notes were published with this episode.
Get every episode summarized
Each time Clinical Chemistry Podcast publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Know when Jane Doe turns up
Follow Jane Doe and once a week we email you every new episode they appeared on — including guest spots the show notes never mention, because we read the transcript.
Follow Jane DoeFree. Pick your own day and time.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Clinical Chemistry Podcast
Alpha-Synuclein-Specific RT-QuIC As a Tool for the Differential Diagnosis of Neu...
Clinical Chemistry Podcast
Predictive Biomarkers for Immune Checkpoint Inhibitor Efficacy: Challenges, Inno...
Clinical Chemistry Podcast
Tumor-Derived HAVCR1 As a Reliable Fluid Biomarker for the Diagnosis of CNS Lymp...
Clinical Chemistry Podcast
Audio Summary September 2026
Clinical Chemistry Podcast